SCHEMBL13020668

SCHEMBL13020668

CC1C(C)[C@@H](COP(C)(=O)OC2C(C)[C@@H](CO)O[C@H]2C)O[C@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13020665 0.87 — —
SCHEMBL13020673 0.73 FBP1 (0.34) —
SCHEMBL17445995 0.71 — —
SCHEMBL25739835 0.71 ALDH1A1 (0.31) —
SCHEMBL13941500 0.71 ALDH1A1 (0.31) —
SCHEMBL13784394 0.71 ALDH1A1 (0.31) —
SCHEMBL12923257 0.71 ALDH1A1 (0.31) —
SCHEMBL13020684 0.71 ALDH1A1 (0.31) —
SCHEMBL14845413 0.71 ALDH1A1 (0.31) —
SCHEMBL19728867 0.69 ALDH1A1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100331397-A1 2-5A ANALOGS AND THEIR METHODS OF USE ALIOS BIOPHARMA, INC. (US) 2010-12-30 — — US disclosed
Send feedback